Pith. sign in

REVIEW

Trial emulation and survival analysis for disease incidence registers: a case study on the causal effect of pre-emptive kidney transplantation

Not yet reviewed by Pith; the record is open.

This paper has not been read by Pith yet. Machine review is queued; the pith claim, tier, and objections will appear here once it completes.

SPECIMEN: schema-true, not a live event

T0 review · schema-true

One-sentence machine reading of the paper's core claim.

pith:XXXXXXXX · record.json · timestamp

arxiv 2011.11771 v1 pith:3BEUDTNE submitted 2020-11-23 stat.AP

classification stat.AP
keywords treatmentsurvivalcausaldiseaseeffectfeaturestimeanalysis
verification ladder T0 review T1 audit T2 compute T3 formal

Signed reviews

No signed human review yet.

0 comments
read the original abstract

Numerous tutorials and research papers focus on methods in either survival analysis or causal inference, leaving common complications in medical studies unaddressed. In practice one must handle problems jointly, without the luxury of ignoring essential features of the data structure. In this paper, we follow incident cases of end-stage renal disease and examine the effect on all-cause mortality of starting treatment with transplant, so-called pre-emptive kidney transplantation, versus dialysis. The question is relatively simple: which treatment start is expected to bring the best survival for a target population? To address the question, we emulate a target trial drawing on the Swedish Renal Registry to estimate a causal effect on survival curves. Aware of important challenges, we see how previous studies have selected patients into treatment groups based on events occurring post treatment initiation. Our study reveals the dramatic impact of resulting immortal time bias and other typical features of long term incident disease registries, including: missing or mismeasured covariates during (the early) phases of the register, varying risk profile of patients entering treatment groups over calendar time and changes in risk as care improves over the years. With characteristics of cases and versions of treatment evolving over time, informative censoring is introduced in unadjusted Kaplan-Meier curves and also their IPW version is no longer valid. Here we discuss feasible ways of handling these features and answer different research questions relying on the no unmeasured baseline confounders assumption.

Discussion (0). Continue with ORCID to comment.

Pith tools